Research Article | | Peer-Reviewed

Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases

Received: 27 November 2024     Accepted: 11 December 2024     Published: 30 December 2024
Views:       Downloads:
Abstract

The study of chemical constituents is an essential element in the valorization of medicinal plants, which can be used to treat a number of pathologies. This work aims to contribute to a better understanding of the chemical composition of Paullinia pinnata (Sapindaceae), a medicinal plant used in Côte d'Ivoire for the traditional treatment of cardiovascular diseases. This study explores the relationship between the compounds identified in this plant and its use in cardiovascular disease treatment. Extraction methods (solid/liquid and liquid/liquid) and identification by GC-MS and HPLC-ESI-QTOF-MS analyses were used. The GC-MS analysis of the various extracts (hexane, dichloromethane and ethyl acetate) identified 32 compounds consisting of steroids, triterpenes, fatty acids, alkaloids and phenolic compounds. HPLC-ESI-QTOF-MS analysis of these extracted memes identified 21 phenolic compounds. In total 53 compounds were identified with the two analytical methods used. These molecules identified are: palmitic acid, 9-(E)-octadecenoic acid, stigmasterol, β-Sitosterol, umbelliferone, epicatechin quinone, clemiscosin A, caffeic acid, catechin, epicatechin and O-β-D-glucopyranosyloxy-4-methyl-2 (5 H)-furanone, cinnamtannin B-2; cinnamtannin B1, procyanidin B2, epicatechin quinone, clemiscosin C, clemiscosin A, kaempferide and epicatechin. These compounds have been identified for their antioxidant, anti-free radical, cardiotonic, neuroprotective and anti-inflammatory properties. The presence of these compounds could justify the use of Paullinia pinnata in the traditional treatment of cardiovascular diseases.

Published in World Journal of Applied Chemistry (Volume 9, Issue 4)
DOI 10.11648/j.wjac.20240904.12
Page(s) 61-68
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Phytochemical Study, Paullinia pinnata, GC-MS, HPLC-ESI-QTOF-MS

1. Introduction
Cardiovascular disease, a group of disorders affecting the heart and blood vessels, is one of the world's leading causes of death. They affect vital organs such as the heart, brain, lungs and kidneys, and can also be a source of disability or chronic morbidity . According to a study published by the World Health Organization (WHO), the number of deaths attributable to cardiovascular disease is estimated at 17.7 million, or 31% of global mortality. The direct cost of treating these diseases is very high . In Africa, particularly in Côte d'Ivoire, despite government efforts to bring improved care services closer to the population, the morbidity rate is rising sharply due to a lack of financial resources, care materials and the high cost of medicines .
Which means that today cardiovascular diseases have become a real public health problem throughout the African region. To address this problem, WHO encourages African countries to develop regional strategies taking into account traditional medicine, to undertake research on medicinal plants and promote their optimal uses in health delivery systems . What's more, the World Health Organization considers traditional medicine to be a vehicle for access to low-cost healthcare, since it uses mainly plant-based therapies. Plants have always been an important source of medicines for mankind. . The pharmacological properties of plants are justified by the active compounds they contain. In this context, a recent study carried out on plants with cardiovascular properties in Côte d'Ivoire showed that Paullinia pinnata possessed good antioxidant activity and a high total polyphenol content. . In view of Paullinia pinnata's many therapeutic virtues (anticancer, antimicrobial and antioxidant) , it is important to carry out further phytochemical studies. The present study aims to extract and identify biomolecules by GC-MS and HPLC-ESI-QTOF-MS analysis, in order to justify its use in traditional medicine.
2. Materiel and methods
2.1. Materiel
The plant material consists of Paullinia pinnata root barks. They were collected in Adiapodoumé (southern Côte d'Ivoire) in November 2019. They were identified and authenticated by Mr. TEHE in com-parison with herbariums available (N085 DOUGOUNE 2006) at the National Center for Agronomic Research located in Adiapodoumé (NCAR-Côte d'Ivoire). The barks were dried at room temperature for 3 weeks in the laboratory, sheltered from the light. The dried bark was crushed using a grinder and sorted. The crushed material was stored at 10°C until further use.
2.2. Methods
2.2.1. Sample Preparation
500 g of Paullinia pinnata root powder are macerated in 1500 mL of methanol (MeOH) with permanent mechanical stirring for 24 h. The operation is repeated 3 times with the same substrates. After filtration, the extracts obtained are combined, then concentrated at 40°C on a rotary evaporator. The residue obtained is then taken up in aqueous methanol (10% MeOH). The solution obtained is successively extracted with hexane (3 × 100 mL), dichloromethane (3 × 100 mL) and ethyl acetate (3 × 100 mL). The different organic fractions are recovered and concentrated in a rotary evaporator under reduced pressure, then stored in the refrigerator for later use.
2.2.2. GC-MS Analysis
Volatile compounds were analyzed by GC-MS. This consisted of an Agilent LC-MS system combined with a Shimadzu HPLC system, model QP2010SE. For this purpose, derivatization was carried out using three (3) mg of each extract (hexane, dichloromethane and ethyl acetate) obtained after extraction, added to 0.5 ml of distilled CH2Cl2 and 0.2 ml of MSTFA (N-methyl-N-(trimethylsilyl) trifluoroacetamide).
After 12 h incubation at room temperature, the CH2Cl2 -MSTFA mixture was condensed on a rotary evaporator. The dry residue was taken up with 1 ml CH2Cl2. The volume of extract injected using a pillbox was 1 μL. The initial oven temperature was 50°C for 2.5 min, and the gradual temperature increase was programmed at 22°C/min up to 250°C, and maintained at this temperature for 30 min. Injector and detector temperatures were set at 200°C and 280°C respectively. Injection was performed in Scan mode. The mass spectrometer parameters for the electron impact mode were 280°C for temperature, 70 eV for electron energy, 50 scans/s for scan speed and 10,000 u.m.a/s for acquisition speed. Compounds were identified by comparing the recorded spectra with those in the database (NIST08.LIB), and by referring to data in the literature.
2.2.3. HPLC-ESI-QTOF-MS Analysis
The analysis of thermosensitive compounds or very large and/or polar molecular masses was carried out by HPLC-ESI-QTOF-MS. It is composed of an Agilent LC-MS system associated with an Agilent 1260 Infinity HPLC system coupled to an Agilent 6530 Q-TOF-MS equipped with a positive ESI source.
Samples were prepared with one (1) mg of each extract (hexane, dichloromethane and ethyl acetate) dissolved in one (1) ml of HPLC grade methanol. The sample injection volume was set at 5µL. A Sunfire C18 analytical column (150 × 2.1 mm; 3.5 μm, Waters) was used, with a flow rate of 250 μL/min and a linear two-solvent gradient: solvent A (95-0% H2O + 0.1% formic acid), solvent B (5-100% B (ACN), organic solvent) for 30 minutes. ESI conditions were defined with a capillary temperature of 320°C, a source voltage of 3.5 kV and a gas flow rate of 10 L/min. In the positive ion mode, purine C5H4N4 (ion at m/z 121.050873 g/mol) and phosphazene C18H18F24N3O6P3 (ion at m/z 922.009 798 g/mol) were used as internal locking masses. Full scans were acquired at a resolution of 11,000 (at m/z 922). The chromatographic characteristics of the main compounds detected on the various chromatograms were determined using UV spectrometry at 254 and 280 nm and high-performance liquid chromatography-mass spectrometry. These data were compared with those in the literature3.
3. Results and Discussion
3.1. Liquid / Liquid Extraction
The yield of the liquid-liquid extraction of Paullinia pinnata's extract is shown in Table 1.
Table 1. Liquid-liquid extraction yield of the methanol extract of Paullinia pinnata.

Extracts

Extracts weight (g)

Yields (%)

Paullinia pinnata

Hexanic

4.650

0.93

Dichloroethane

0.350

0.07

Ethyl acetate

3

0.6

The liquid-liquid extraction yield of the methanol extract of Paullinia pinnata made it possible to notice a variation in yield from one extract to another. The hexane and ethyl acetate extracts of Paullinia pinnata showed better yields compared to that of di-chloromethane. The highest yields are obtained with the hexane (0.93%) and ethyl acetate (0.6%) extracts. These two different extracts would contain more mass-extractable phytocompounds than in dichloromethane.
3.2. Characterization of Paullinia Pinnata Extracts by GC-MS
Gas chromatography coupled with mass spectroscopy (GC-MS) was carried out with the aim of identifying the different compounds contained in the root fractions of Paullinia pinnata. The identification of the different characteristic peaks was carried out by comparing the mass fragmentations with those available in the NIST 98 and Wiley 275 libraries and with those published in the literature. Figures 1, 2 and 3 present the GC chromatograms of the different extracts.
3.3. Characterization by HPLC-ESI-QTOF-MS of the Various Extracts from Paullinia pinnata
The different molecules detected were characterized by the study of their fragmentations obtained by ESI-QTOF-MS in positive mode, in comparison with data obtained from the literature on botanical species or in the genus. The chromatograms obtained in positive mode (ESI-QTOF-MS) of the different extracts of Paullinia pinnata were observable under UV 254nm. Figures 4, 5 and 6 present the HPLC chromatograms of the different extracts.
The GC-MS chromatographic profile of the hexane extract (Figure 1) of Paullinia pinnata identified 7 compound peaks, consisting of 2 (two) steroids, 1 (one) alcohol and 1 (one) alkaloid and 3 (three) fatty acids.
Figure 1. GC-MS analysis of the Paullinia pinnata hexane extract.
Retention times range from 10.94 min to 17.51 min. The main components are: hexadecenoic acid (tr=10.94; 4.95%), octadec-9-Z enol (tr=11.31; 0.55%), 6-Z-octadecenoic acid (tr=11.38; 2.4%), 9-Eoctadecenoic acid (tr= 11.68; 1.07%), acetate-3-β stigmasta-5,22-dien-3-ol (tr= 17.10; 0.97%), sitosterol (tr= 17.51; 0.92%) and Ibogamine-18-carboxylic acid, 12-methoxy-, methyl ester (tr= 15.56; 86.51%), as the majority peak.
The GC-MS chromatographic profile of the dichloromethane extract (Figure 2) of Paullinia pinnata made it possible to identify 11 peaks of compounds consisting of 3 (three) steroids, 4 (four) alcohols, 1 (one) triterpene and 3 (three) fatty acids. The retention time ranged from 10.17 min to 17.90 min. The main components are: nonadecanol (tr=10.17; 3.5%), oct-tadecanoic acid (tr= 10.53; 10.94%), 9-octadecene-1-ol (tr= 11; 11.35%), heneicosan-1-ol (tr= 11.10; 5.55%), 9-Z-hexadecenal (tr= 11.32; 11.1%), octadecanoic acid (tr= 11.41; 3.35%), eicosane (tr= 12.36; 2.34%), 3-β-ergost-5-èn-3-ol (tr= 16.84; 3.57%), stigmasterol (tr= 17; 3.84%), lup-20(29)-èn-3-one (tr=17.90; 2.91%) and sitosterol (tr=17.41; 15.84%) as the majority peak.
Figure 2. GC-MS analysis of the Paullinia pinnata dichloromethane extract.
The GC-MS chromatographic profile of the ethyl acetate extract (Figure 3) of Paullinia pinnata identified 14 compound peaks, grouped into 3 (three) steroids, 1 (one) alcohol, 1 (one) alkaloid, 1 (one) glycoside, 3 (three) polyphenols and 5 (five) fatty acids.
Retention times ranged from 5.93 min to 17.51 min. The main components identified were: phenol (tr= 5.93; 0.38%), glycerol (tr= 6.74; 4.78%), nonanoic acid (tr= 7.38; 0.28%), catechin (tr= 9.97; 0.83%), oleanitrile (tr= 11.15; 4.71%), octadec-9-Z-enol (tr= 11.30; 1.82), heptadecanoic acid (tr= 11.36; 0.62%), 9-E-octadecenoic acid (tr= 11.67; 3.72%), scopoline (tr= 12.18; 0.29%), β-D-glucopyranosyl thymol (tr= 12.54; 0.19%), cholesterol (tr= 16.34; 0.29%), stigmasterol (tr= 17.10; 1.83%), sitosterol (tr= 17.51; 4.84%) and palmitic acid (tr= 10.94; 8.61%) as the major peak. In summary, GC-MS analysis of various Paullinia pinnata root extracts identified twenty-nine (29) compounds, including palmitic acid, 9-(E)-octadecenoic acid, stigmasterol, sitosterol and catechin, recognized for their antioxidant, antiradical, cardiotonic, neuroprotective, hypocholesterolemic, im-munostimulant and inflammatory properties .
Figure 3. GC-MS analysis of the Paullinia pinnata dichloromethane extract.
Figure 4 shows the HPLC-ESI-QTOF-MS chromatogram of the hexane extract of Paullinia pinnata. It identified seven (7) peaks of polyphenol-type compounds. These are umbeliferone (tr= 21min), epicatechin quinone (tr= 22.13 min), clemiscosin A (tr= 23 min), caffeic acid (tr= 24.87 min), catechin (tr= 32.26 min), O-β-D-glucopyranosyloxy -4-methyl-2 (5 H)- furanone (tr= 35.18 min) and epicatechin (tr= 33.35 min) as the major peak.
Figure 5 shows the HPLC-ESI-QTOF-MS chromatogram of the dichloromethane extract of Paullinia pinnata, identifying five (5) compound peaks grouped into five (5) polyphenols. Scopoletin (tr= 19.24 min), umbelliferone (tr= 20.94 min), clemiscosin C (tr= 22.13 min), kaempferide (tr= 28.66 min) and O-β-D-glucopyranosyloxy -4-methyl2 (5 H)-furanone (tr= 33.15 min) as majority peak.
Figure 6 shows the HPLC-ESI-QTOF-MS chromatographic profile of the ethyl acetate extract, identifying nine (9) peaks of compounds grouped into nine (9) polyphenols. O-β-D-glucopyranosyloxy -4-methyl-2 (5 H)-furanone (tr= 2.05 min), cinnamtannin B-2 (tr= 12.67 min), procyanidin B-2(tr= 15.84 min), epicatechin quinone (tr= 16.16 min), clemiscosin C (tr= 22.79 min), clemiscosin A (tr= 23.33 min), kaempferide (tr= 32.70 min), epicatechin (tr= 33.10 min) and cinnamtannin B-1(tr= 15.59 min) as the major peak.
Figure 4. HPLC-ESI-QTOF-MS analysis of the Paullinia pinnata hexane extract.
Figure 5. HPLC-ESI-QTOF-MS analysis of the Paullinia pinnata dichloromethane extract.
Figure 6. HPLC-ESI-QTOF-MS analysis of the Paullinia pinnata ethyl acetate extract.
HPLC-ESI-QTOF-MS analyses of various Paullinia pinnata root extracts identified fourteen (14) compounds, including umbeliferone, epicatechin quinone, clemiscosin A, caffeic acid, catechin, epicatechin and O-β-D-glucopyranosyloxy -4-methyl-2 (5 H)-furanone, cinnamtannin B-2, cinnamtannin B-1, procyanidin C-1, procyanidin B-2, scopoletin, clemiscosin C and kaempferol (figure 7) are well-known for their antioxidant, antiradical, cardiotonic and hypocholesterolemic neuroprotective properties; Immunostimulant and inflammatory .
The present work has highlighted the various compounds contained in Paullinia pinnata. The biomolecules identified by CPG-MS analysis are in line with the work carried out by Ouattara et al., 2019. Indeed, according to the studies carried out by this team, the molecules identified consist of fatty acids, polyphenols and carbohydrates . Our results obtained after HPLC-ESI-QTOF analysis confirm those carried out by Kassi et al. Their studies revealed that Paullinia pinnata possesses significant antioxidant properties due to the presence of polyphenols (flavonoids) and alkaloids in extracts from this plant . These bioactive metabolites present in Paullinia pinnata are associated with beneficial effects on heart health. These compounds may help reduce inflammation and improve blood circulation . This is crucial for the prevention of cardiovascular disease.
The literature shows that plants rich in polyphenols are associated with a reduced risk of cardiovascular disease. These studies validate that treatment of cells with polyphenols counteracts the oxidative stress burden and influences signaling pathways to reduce risk associated with cardiovascular disease, and confirms their therapeutic efficacy .
Its antihypertensive and antioxidant properties, as well as the cardioprotective effects of the molecules present in this plant, make it a preferred choice in traditional medicine.
In short, Paullinia pinnata is valued in traditional medicine for its potential effects on cardiovascular health, underlining the importance of scientific research to better understand and validate these traditional uses.
Figure 7. Structures of compounds identified in different extracts from pp roots.
4. Conclusion
The completion of this work is part of a better knowledge of the chemical composition of a medicinal plant (Paullinia pinnata) from Ivory Coast, used in the traditional treatment of cardiovascular diseases. This, through the discovery of biomolecules with antioxidant properties in order to justify its use in traditional medicine. To do this, two chromatography methods coupled with mass spectrometry were used. Namely gas chromatography coupled with mass spectroscopy (GC-MS) and high-performance liquid chromatography coupled with mass spectrometry and quadrupole-Time-of (HPLC-ESI-QTOF-MS). GC-MS analyzes of different extracts (hexane, dichloromethane and ethyl acetate) of Paullinia pinnata roots made it possible to identify twenty-nine (29) compounds including palmitic acid, 9-acid (E) octadecenoic acid, stigmasterol, sitosterol, catechin are recognized for their antioxidant, antiradical, cardiotonic, neuroprotective, hypocholesterolemic; immunostimulating and inflammatory. The HPLC-ESI-QTOF-MS analysis of the different extracts (hexane, dichloromethane and ethyl acetate) of Paullinia pinnata made it possible to identify fourteen (14) compounds including umbelliferone, epicatechin quinone, clemiscosin A, caffeic acid, catechin, epicatechin and O-β-D-glucopyranosyloxy -4-methyl-2(5H)-furanone, cinnamtannin B-2, cinnamtannin B-1, procyanidin C-1, procyanidin B-2, scopoletin, clemiscosin C, kaempferide are recognized for their antioxidant, anti-radical, cardiotonic, hypocholesterolemic neuroprotective properties; immunostimulating and inflammatory. These results obtained show that Paullinia pinnata root extracts are made up of molecules with antioxidant, neuroprotective and inflammatory properties, which would justify the use of this plant in the treatment of cardiovascular diseases.
Paullinia pinnata is a key component of the traditional pharmacopoeia for cardiovascular disease. Its hypotensive, antioxidant and circulatory properties make it a valuable plant for cardiac well-being. However, its use must be regulated to ensure its effectiveness and avoid risks.
Abbreviations

HPLC

High Performance Liquid Chromatography

MS

Mass Spectrometry

GC

Gas Chromatography

UV

Ultra-Violet

ESI

Electrospray Ionization

QTOF

Quadrupole Time-of-Flight

Acknowledgments
This work was funded by the Ministry of Higher Education and Scientific Research of Côte d’Ivoire.
Author Contributions
Jeanne Bervis Adjadi: Formal analysis, Writing – original draft, Writing – review & editing
Amian Brise Benjamin Kassi: Conceptualization, Supervision, Validation, Funding acquisition
Daouda Ballo: Conceptualization, Supervision, Funding acquisition
Nikiema Diakaridja: Formal analysis, Writing – review & editing
Virieux David: Supervision
Jean-Luc Pirat: Supervision
Funding
Ministry of Higher Education and Scientific Research of Côte d’Ivoire.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] OMS, «Cardiovascular diseases (CVDs)». 2021
[2] J. Leal, R. Luengo-Fernandez, A. Gray, S. Petersen and M. Rayer, "Economic burden of cardiovascular diseases in the enlarged European Union," European Heart Journal, vol. 27, pp. 1610–1619, 2006,
[3] Ministère de la Santé et de l’Hygiène Publique, "Rapport Annuel sur la Situation Sanitaire (RASS) ", [Annual Health Situation Report (RASS)], Edition 2019,
[4] Ministère de la Santé et de la Lutte contre le SIDA, " Promouvoir le rôle de la médecine traditionnelle dans les systèmes de santé: Programme National de Promotion de la Médecine Traditionnelle", [Promoting the role of traditional medicine in health systems: National Program for the Promotion of Traditional Medicine] 2014
[5] C. Wiart, " Medicinal plants of the Asia-pacific drugs for the futures", 2006,
[6] M. Bouquet et Debray, "Plante Médicinales de la Côte D’ivoire", 1974.
[7] A. B. B. Kassi., D. Ballo, A. F. Kabran, D. Sissouma et A. Ané, "Evaluation du pouvoir antioxydant et de la teneur en polyphénols totaux de six plantes médicinales utilisées dans le traitement des maladies cardiovasculaires", [Evaluation of the antioxidant power and total polyphenol content of six medicinal plants used in the treatment of cardiovascular disease.] Journal of Applied Biosciences, vol. 153, pp. 15788 – 15797, 2020,
[8] J. D. Tamokou, J. R. Chouna, E. Fischer-Fodor, G. Chereches, O. Barbos, G. Damian, R. Silaghi-Dumitrescu, "Anticancer and Antimicrobial Activities of Some Antioxidant-Rich Cameroonian Medicinal Plants", PLoS ONE, vol. 8(2), pp. 55880, 2006,
[9] A. Kofi, G. Raghavan, K. Emelia, "Wound Healing and Cytoprotective Actions of Paullinia pinnata L. ", Pharmacognosy Journal, vol. 2 (10), pp. 345-350, 2010,
[10] E. S. Iful, "Studies On the Antivenom Activities of the Aqueous Extracts of Paullinia Pinnata and Detarium Microcarpum Against Echis Carinatus (Carpet Viper) Venom" Ph.D. University of Jos, 2008,
[11] I. M. Maje, J. A. Anuka, I. M. Hussaini, U. A. Katsayal, A. H. Yaro, M. G. Magaji, Y. Jamilu, M. Sani and Y. Musa, "Evaluation of the anti-malarial activity of the ethanolic leaves extract of Paullinia pinnata L. (sapindaceae)", Nig. Journ. Pharm. Sci., vol. 6(2), pp. 67-77, October 2007,
[12] D. G. Kumar and R. Rajakumar, "Gas chromatography mass spectrometry analysis of bioactive components from the ethanol extract of Avicennia marina leaves", Innovare Journal of Science, vol. 4(4), pp. 9-12, 2016,
[13] A. R. Mehtiev and A. Yu Misharin, "Biological activity of phytosterols and their derivatives", Biomedical Chemistry, vol. 2(1), pp. 1–17, 2008,
[14] S. Bapia, N. Srisombata, S. Ratanabunyong, K. Choowongkomon, S. Vajrodaya, N. Wongkantrakorn, S. Duangsrisai, "Isolation of stigmasterol from Kra Don (Careya arborea Roxb.) and bioactivities of its crude extracts against free radicals and human immunodeficiency virus"; Agr. Nat. Resour, vol. 55, pp 33–42, 2021,
[15] S. Hidayathulla, A. A. Shahat, S. R. Ahamad A. A. N. Al Moqbil, M. S. Alsaid and D. D. Divakar, "GC/MS analysis and characterization of 2-Hexadecen-1-ol and beta sitosterol from Schimpera arabica extract for its bioactive potential as antioxidant and antimicrobial", Journal of Applied Microbiology, vol. 124(5), 2018,
[16] R. P. Fagundes, M. F. Ferreira, A. Gower, M. Chiarello, B. Canci, M. Roesch-Ely, P. F. Reisdorfer and S. Moura, "Bio-guided search of active indole alkaloids from Tabernaemontana catharinensis, antitumour activity, toxicity in silico and molecular modeling", Bioorganic Chemistry, 2018,
[17] D. Yu, T. Huang, B. Tian, J. Zhan, "Advances in Biosynthesis and Biological Functions of Proanthocyanidins in Horticultural Plants", Foods, vol. 9, pp. 1774, 2020,
[18] K. Yokota, H. Kimura, S. Ogawa and, T. Akihiro; "Analysis of A-type and B-type highly polymeric proanthocyanidins and their biological activities as nutraceuticals", Journal of Chemistry, vol. 1–7, 2013.
[19] S. Ogawa, H. Kimura, A. Niimi, T. Kastube, M. Jisaka, K. Yokota; "Fractionation and structural characterization of polyphenolic antioxidants from seed shells of Japanese horse chestnut (Aesculus turbinata Blume)"; J. Agric. Food Chem., vol. 56, pp. 12046, 2008,
[20] M. Taher,"Isolation and in vitro antidiabetic properties of a proanthocyanidin from Cinnamomum zeylanicum", Thèse soutenue en 2005.
[21] Yokozawa T., Cho E. J., Park C. H. and Kim J. H.; "Protective effect of proanthocyanidin against diabetic oxidative stress; Evidence-Based Complementary and Alternative Medicine, 2012, 1–11.
[22] H. Kimura, S. Ogawa, A. Sugiyama, M. Jisaka, K. Yokota, "Anti-obesity effects of highly polymeric proanthocyanidins from seed shells of Japanese horse chestnut (Aesculus turbinata Blume)", Food Res. Int., vol. 44, pp. 121-140, 2011.
[23] Ouattara L. H., Kabran G. R. M., Konan K. M., Koffi K. L., Koffi K. E., Mamyrbekova-Bekro J. A. and Bekro Y. A 2019. “Biological activities and phytochemical composition of the methanol extract of Paullinia pinnata Linn. stems from Côte d’Ivoire”, International Journal of Current Research, 11, (10), 728-7733.
[24] I. Iqbal et al., «Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A Review», Molecules, vol. 28, no 17, p. 6403, Sept. 2023,
[25] S. Khurana, K. Venkataraman, A. Hollingsworth, M. Piche, et T. C. Tai, «Polyphenols: Benefits to the Cardiovascular System in Health and in Aging», Nutrients, vol. 5, no 10, p. 3779-3827, Sept. 2013,
Cite This Article
  • APA Style

    Adjadi, J. B., Kassi, A. B. B., Ballo, D., Diakaridja, N., David, V., et al. (2024). Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases. World Journal of Applied Chemistry, 9(4), 61-68. https://doi.org/10.11648/j.wjac.20240904.12

    Copy | Download

    ACS Style

    Adjadi, J. B.; Kassi, A. B. B.; Ballo, D.; Diakaridja, N.; David, V., et al. Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases. World J. Appl. Chem. 2024, 9(4), 61-68. doi: 10.11648/j.wjac.20240904.12

    Copy | Download

    AMA Style

    Adjadi JB, Kassi ABB, Ballo D, Diakaridja N, David V, et al. Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases. World J Appl Chem. 2024;9(4):61-68. doi: 10.11648/j.wjac.20240904.12

    Copy | Download

  • @article{10.11648/j.wjac.20240904.12,
      author = {Jeanne Bervis Adjadi and Amian Brise Benjamin Kassi and Daouda Ballo and Nikiema Diakaridja and Virieux David and Jean-Luc Pirat},
      title = {Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases
    },
      journal = {World Journal of Applied Chemistry},
      volume = {9},
      number = {4},
      pages = {61-68},
      doi = {10.11648/j.wjac.20240904.12},
      url = {https://doi.org/10.11648/j.wjac.20240904.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjac.20240904.12},
      abstract = {The study of chemical constituents is an essential element in the valorization of medicinal plants, which can be used to treat a number of pathologies. This work aims to contribute to a better understanding of the chemical composition of Paullinia pinnata (Sapindaceae), a medicinal plant used in Côte d'Ivoire for the traditional treatment of cardiovascular diseases. This study explores the relationship between the compounds identified in this plant and its use in cardiovascular disease treatment. Extraction methods (solid/liquid and liquid/liquid) and identification by GC-MS and HPLC-ESI-QTOF-MS analyses were used. The GC-MS analysis of the various extracts (hexane, dichloromethane and ethyl acetate) identified 32 compounds consisting of steroids, triterpenes, fatty acids, alkaloids and phenolic compounds. HPLC-ESI-QTOF-MS analysis of these extracted memes identified 21 phenolic compounds. In total 53 compounds were identified with the two analytical methods used. These molecules identified are: palmitic acid, 9-(E)-octadecenoic acid, stigmasterol, β-Sitosterol, umbelliferone, epicatechin quinone, clemiscosin A, caffeic acid, catechin, epicatechin and O-β-D-glucopyranosyloxy-4-methyl-2 (5 H)-furanone, cinnamtannin B-2; cinnamtannin B1, procyanidin B2, epicatechin quinone, clemiscosin C, clemiscosin A, kaempferide and epicatechin. These compounds have been identified for their antioxidant, anti-free radical, cardiotonic, neuroprotective and anti-inflammatory properties. The presence of these compounds could justify the use of Paullinia pinnata in the traditional treatment of cardiovascular diseases.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Characterization of Paullinia pinnata (Sapindaceae) Root Extracts by GC-MS and HPLC-ESI-QTOF-MS: An Ivorian Medicinal Plant at the Service of Cardiovascular Diseases
    
    AU  - Jeanne Bervis Adjadi
    AU  - Amian Brise Benjamin Kassi
    AU  - Daouda Ballo
    AU  - Nikiema Diakaridja
    AU  - Virieux David
    AU  - Jean-Luc Pirat
    Y1  - 2024/12/30
    PY  - 2024
    N1  - https://doi.org/10.11648/j.wjac.20240904.12
    DO  - 10.11648/j.wjac.20240904.12
    T2  - World Journal of Applied Chemistry
    JF  - World Journal of Applied Chemistry
    JO  - World Journal of Applied Chemistry
    SP  - 61
    EP  - 68
    PB  - Science Publishing Group
    SN  - 2637-5982
    UR  - https://doi.org/10.11648/j.wjac.20240904.12
    AB  - The study of chemical constituents is an essential element in the valorization of medicinal plants, which can be used to treat a number of pathologies. This work aims to contribute to a better understanding of the chemical composition of Paullinia pinnata (Sapindaceae), a medicinal plant used in Côte d'Ivoire for the traditional treatment of cardiovascular diseases. This study explores the relationship between the compounds identified in this plant and its use in cardiovascular disease treatment. Extraction methods (solid/liquid and liquid/liquid) and identification by GC-MS and HPLC-ESI-QTOF-MS analyses were used. The GC-MS analysis of the various extracts (hexane, dichloromethane and ethyl acetate) identified 32 compounds consisting of steroids, triterpenes, fatty acids, alkaloids and phenolic compounds. HPLC-ESI-QTOF-MS analysis of these extracted memes identified 21 phenolic compounds. In total 53 compounds were identified with the two analytical methods used. These molecules identified are: palmitic acid, 9-(E)-octadecenoic acid, stigmasterol, β-Sitosterol, umbelliferone, epicatechin quinone, clemiscosin A, caffeic acid, catechin, epicatechin and O-β-D-glucopyranosyloxy-4-methyl-2 (5 H)-furanone, cinnamtannin B-2; cinnamtannin B1, procyanidin B2, epicatechin quinone, clemiscosin C, clemiscosin A, kaempferide and epicatechin. These compounds have been identified for their antioxidant, anti-free radical, cardiotonic, neuroprotective and anti-inflammatory properties. The presence of these compounds could justify the use of Paullinia pinnata in the traditional treatment of cardiovascular diseases.
    
    VL  - 9
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Laboratory of Constitution and Reaction of Matter, Unity of Formation and Research Science of Structure Matter and Technology, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire; Institut Charles Gerhard de Montpellier), University of Montpellier, National Center for Scientific Research, National Higher School of Chemistry of Montpellier, Montpellier, France

  • Laboratory of Constitution and Reaction of Matter, Unity of Formation and Research Science of Structure Matter and Technology, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

  • Laboratory of Constitution and Reaction of Matter, Unity of Formation and Research Science of Structure Matter and Technology, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

  • Laboratory of Constitution and Reaction of Matter, Unity of Formation and Research Science of Structure Matter and Technology, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

  • Institut Charles Gerhard de Montpellier), University of Montpellier, National Center for Scientific Research, National Higher School of Chemistry of Montpellier, Montpellier, France

  • Institut Charles Gerhard de Montpellier), University of Montpellier, National Center for Scientific Research, National Higher School of Chemistry of Montpellier, Montpellier, France